首页/数据集/Anti-HIV-1 (X4) activity of CXCR4 compounds evaluated in CD4-positive MT-4 cells and PHA-stimulated PBMCs.

Anti-HIV-1 (X4) activity of CXCR4 compounds evaluated in CD4-positive MT-4 cells and PHA-stimulated PBMCs.

NIAID Data Ecosystem2026-03-10 收录

数据链接：

https://figshare.com/articles/dataset/Anti-HIV-1_X4_activity_of_CXCR4_compounds_evaluated_in_CD4-positive_MT-4_cells_and_PHA-stimulated_PBMCs_/4879280 数据链接链接失效反馈

官方服务：

资源简介：

Anti-HIV-1 (X4) activity of CXCR4 compounds evaluated in CD4-positive MT-4 cells and PHA-stimulated PBMCs.

应用场景：

创建时间：

2017-04-15

蛋白质晶体学

抗HIV药物研发

Crystal structure of the Myxococcus Xanthus hemagglutinin (MBHA) Descriptor: Myxobacterial hemagglutinin Authors: Koharudin, L.M.I, Gronenborn, A.M. Deposit date: 2012-05-23 Release date: 2012-08-15 L

Protein Data Bank Japan2023-09-13 更新90

Probing the Dominant Motifs within the Hydrophobic Channel Yields Oxadiazole-Containing Diarylpyrimidine Derivatives as Potent HIV‑1 Non-Nucleoside Reverse Transcriptase Inhibitors

抗HIV药物研发

抗药性抑制

To develop effective non-nucleoside reverse transcriptase inhibitors (NNRTIs) with improved antidrug resistance profiles and drug-like properties, a series of novel diarylpyrimidine derivatives target

NIAID Data Ecosystem40

Discovery of Lenacapavir: First-in-Class Twice-Yearly Capsid Inhibitor for HIV‑1 Treatment and Pre-exposure Prophylaxis

抗HIV药物研发

长效抗病毒疗法

The HIV capsid is essential to the virus lifecycle, making it a promising target for therapeutic intervention. In 2006, a screening campaign was initiated to identify small molecules capable of disrup

Figshare2025-10-01 更新20

8-Modified-2′-Deoxyadenosine Analogues Induce Delayed Polymerization Arrest during HIV-1 Reverse Transcription

抗HIV药物研发

核苷类似物药物设计

The occurrence of resistant viruses to any of the anti-HIV-1 compounds used in the current therapies against AIDS underlies the urge for the development of new drug targets and/or new drugs acting thr

NIAID Data Ecosystem50

Design and Development of Highly Potent HIV‑1 Protease Inhibitors with a Crown-Like Oxotricyclic Core as the P2-Ligand To Combat Multidrug-Resistant HIV Variants

抗HIV药物研发

蛋白酶抑制剂设计

Design, synthesis, and evaluation of a new class of exceptionally potent HIV-1 protease inhibitors are reported. Inhibitor 5 displayed superior antiviral activity and drug-resistance profiles. In fact

Figshare2017-04-18 更新30

Anti-HIV-1 (X4) activity of CXCR4 compounds evaluated in CD4-positive MT-4 cells and PHA-stimulated PBMCs.

资源简介：

相关数据集